Navigation Links
FRC: NIH Stem Cell Guidelines Reflect Poor Science, Ignore Real Hope for Patients
Date:4/17/2009

WASHINGTON, April 17 /PRNewswire-USNewswire/ -- Today, Family Research Council President Tony Perkins responded to the National Institutes of Health (NIH) issued draft guidance for implementing President Obama's executive order to fund embryonic stem cell research (ESCR). President Obama's decision and these guidelines will remove key limits on federal funding of ESCR. Following is Perkins' statement:

(Logo: http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO )

"The research that President Obama supports is not sound science and will destroy human life. And now the NIH draft guidelines demanded by the President will do nothing to advance stem cell research that is showing near-term benefit for suffering patients. Instead, the guidelines implement a plan that will force taxpayers to foot the bill for research that involves human embryo destruction.

"The NIH guidelines will create an incentive to cannibalize the so-called 'leftover embryos,' though they will not fund research on stem cells derived from cloning, parthenogenesis and human-animal hybrids. However, NIH clearly believes the President's executive order allows them to fund such unethical research at any point in the future. The guidelines purport to have tight informed consent requirements, but they don't even require IVF doctors and the stem cell researchers to work separately, thereby opening a gaping loophole for the researchers to increase embryo production for their research.

"Instead of funding more embryo destructive research, the government should fund research using adult stem cells that are on the cutting edge of treating patients for diabetes, spinal cord injury, heart disease, and various cancers. Unfortunately, this draft guidance only diverts limited federal resources to unethical stem cell research that has not successfully treated a single person for any disease.

"Taxpayer funding should instead focus on common ground stem cell research and support legislation like the Patient's First Act sponsored by Rep. Randy Forbes (R-VA) and Rep. Dan Lipinksi (D-IL). Congress also needs to renew the Dickey-Wicker Amendment, which would forbid taxpayer funding of the creation of human embryos solely for their destruction.

"There is great potential in this country for research and procedures that will cure many diseases and allow us to maintain our ethical standards. I urge Members of Congress to support Dickey-Wicker and focus funding on the proven science of adult stem cells."


'/>"/>
SOURCE Family Research Council
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia"
2. The International Society for Stem Cell Research Releases New Guidelines to Shape Future of Stem Cell Therapy
3. British School Kids With Diabetes Gain First Time Freedom From Injections With New Insulin Pump Guidelines
4. Expert Consensus Panel Recommendation for Incorporating Lp-PLA2 Testing into Cardiovascular Disease Risk Assessment Guidelines
5. Pharmaceutical Competitive Intelligence Excellence: Optimizing Data Collection with Approved Guidelines
6. Fungitell(R) CE Marked, Referenced in IDSA and NCCN Guidelines and Added to EORTC-MSG Revised Definitions of Invasive Fungal Disease
7. American Urological Association (AUA) Clinical Guidelines Recognizes Cryotherapy as Treatment Option for Prostate Cancer Patients
8. Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients
9. Biopure Operations Compliant With U.K. Manufacturing Guidelines
10. Long-awaited international ethical guidelines for biobank researchers
11. Updated NIH Guidelines Offer Valuable Information on Asthma Diagnosis and Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... 05, 2016 , ... This composition patent, U.S. Patent No. ... The composition claims are not limited to any particular process to make or ... carbon fibers, graphene, and other materials. A continuation application, U.S. Patent App. ...
(Date:12/5/2016)... , Dec. 5, 2016  Renova™ Therapeutics, ... congestive heart failure and other chronic diseases, announced ... the company as Chief Financial Officer (CFO), effective ... with 20 years of experience in financial management ... biotech and software companies. Most recently, Ms. Bovenizer ...
(Date:12/5/2016)... , December 5, 2016 The ... with almost $108 billion of revenue and some $890 ... were spent on global biopharmaceuticals, and this figure is ... Stock-Callers.com has lined up these four equities for assessment: ... Pharmaceuticals Inc. (NASDAQ: ACAD ), Acorda Therapeutics ...
(Date:12/2/2016)... ... ... In anticipation of AxioMed’s exclusive cleanroom manufacturing facility in ... Lubinski will be traveling to Switzerland from December 5-10. Mr. Lubinski will meet ... to discuss the benefits of a viscoelastic disc. AxioMed received CE mark in ...
Breaking Biology Technology:
(Date:11/30/2016)... SAN FRANCISCO and WARSAW, Poland , Nov. 30, 2016 ... sleeping. It is one of the most crucial aspects of recovery so we need ... host of serious health risks, including heart problems, high blood pressure, stroke, diabetes, and ... family and friends sleep and find a Christmas present that could help them to ... ...
(Date:11/29/2016)... Lithuania , Nov. 29, 2016 /PRNewswire/ ... biometric identification and object recognition technologies, today ... (SDK) for fingerprint recognition solutions that run ... a fingerprint template using less than 128KB ... in compact devices that have limited on-board ...
(Date:11/24/2016)... Cercacor today introduced Ember TM Sport ... non-invasively measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion ... in approximately 30 seconds. Smaller than a smartphone, using ... to key data about their bodies to help monitor ... Hemoglobin carries oxygen to muscles. When hemoglobin ...
Breaking Biology News(10 mins):